Bedel Financial Consulting’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-200
Closed -$22K 389
2022
Q1
$22K Hold
200
0.01% 531
2021
Q4
$24K Hold
200
0.01% 530
2021
Q3
$20K Hold
200
0.01% 551
2021
Q2
$23K Hold
200
0.01% 527
2021
Q1
$22K Hold
200
0.01% 499
2020
Q4
$20K Hold
200
0.01% 451
2020
Q3
$16K Hold
200
0.01% 450
2020
Q2
$14K Sell
200
-6
-3% -$378 0.01% 439
2020
Q1
$10K Buy
206
+6
+3% +$385 0.01% 471
2019
Q4
$16K Hold
200
0.01% 427
2019
Q3
$15K Hold
200
0.01% 422
2019
Q2
$16K Hold
200
0.01% 420
2019
Q1
$15K Hold
200
0.01% 427
2018
Q4
$15K Hold
200
0.01% 401
2018
Q3
$16K Hold
200
0.01% 407
2018
Q2
$20K Hold
200
0.01% 379
2018
Q1
$21K Buy
+200
New +$20.2K 0.02% 376

Other funds holding EMN

Bedel Financial Consulting's EMN Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Eastman Chemical (EMN) in Q2 2022, closing a stake of 200 shares — an estimated $22K sold.

Bedel Financial Consulting first reported a position in EMN in Q1 2018 and held it in 17 quarters. The position peaked at $24K in Q4 2021. 688 funds tracked by Wall St. Rank hold EMN as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Eastman Chemical position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 200 Eastman Chemical shares in Q2 2022, an estimated $22K.
  • Bedel Financial Consulting first reported a position in Eastman Chemical in Q1 2018 and held it in 17 quarters.
  • Bedel Financial Consulting's Eastman Chemical position peaked at $24K in Q4 2021.
  • 688 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.